12:00 AM
Apr 30, 2007
 |  BC Week In Review  |  Company News  |  Deals

Alliant, Sciele deal

SCRX will acquire Alliant for $122 million in cash and up to $55 million in milestones. SCRX, which develops and markets women’s nutritional supplements and products to treat cardiovascular indications and diabetes,...

Read the full 138 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >